Francisco J. Garjon-Parra

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Impact of a antimicrobial stewardship in the community on optimizing the treatment of streptococcal pharyngotonsillitis: a before-and-after intervention study

Impact of a antimicrobial stewardship in the community on optimizing the treatment of streptococcal pharyngotonsillitis: a before-and-after intervention study

Journal: Semergen

Published: March 04, 2026

Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary care.

Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary care.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: January 30, 2026

Population-based deprescribing strategy for proton pump inhibitors: health outcomes from a case-control study.

Population-based deprescribing strategy for proton pump inhibitors: health outcomes from a case-control study.

Journal: Medicina clinica

Published: November 24, 2025

Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis.

Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: November 12, 2025

[Translated article] Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis.

[Translated article] Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: November 12, 2025

Study protocol: evaluation of a pharmaceutical intervention for safe use of medications in patients with liver cirrhosis

Study protocol: evaluation of a pharmaceutical intervention for safe use of medications in patients with liver cirrhosis

Journal: Revista espanola de salud publica

Published: April 01, 2025

Health outcomes of deprescribing proton pump inhibitors: study protocol

Health outcomes of deprescribing proton pump inhibitors: study protocol

Journal: Revista espanola de salud publica

Published: October 31, 2024

Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy?

Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy?

Journal: Gaceta sanitaria

Published: July 05, 2022

Study protocol: A strategy for deprescribing statins and ezetimibe in primary prevention of cardiovascular disease in patients older than 75 years: health outcomes analysis.

Study protocol: A strategy for deprescribing statins and ezetimibe in primary prevention of cardiovascular disease in patients older than 75 years: health outcomes analysis.

Journal: Revista espanola de salud publica

Published: March 11, 2022

Results of implementation of a pilot antimicrobial stewardship program (ASP) in Primary Care

Results of implementation of a pilot antimicrobial stewardship program (ASP) in Primary Care

Journal: Anales del sistema sanitario de Navarra

Published: October 15, 2020

On drug-related mortality in patients admitted to Internal Medicine

On drug-related mortality in patients admitted to Internal Medicine

Journal: Anales del sistema sanitario de Navarra

Published: December 21, 2019

The reliability of clinical trials. The risky way towards drug deregulation.

The reliability of clinical trials. The risky way towards drug deregulation.

Journal: Medicina clinica

Published: October 03, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026